Phathom Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.About PHAT
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
PHAT Key Statistics
Stock Snapshot
With a market cap of 1.01B, Phathom Pharmaceuticals(PHAT) trades at $12.70. The stock has a price-to-earnings ratio of -5.97.
On 2026-05-06, Phathom Pharmaceuticals(PHAT) stock moved within a range of $12.59 to $12.90. With shares now at $12.70, the stock is trading +0.8% above its intraday low and -1.6% below the session's peak.
Trading activity shows a volume of 89.43K, compared to an average daily volume of 1.96M.
The stock's 52-week range extends from a low of $2.21 to a high of $18.31.
The stock's 52-week range extends from a low of $2.21 to a high of $18.31.
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.